Pliant Therapeutics (PLRX) Change in Cash (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Change in Cash of -$23.3 million for Q1 2026, down 212.08% year-over-year from $20.7 million in Q1 2025, and up 51.84% quarter-over-quarter from -$48.3 million in Q4 2025.
Pliant Therapeutics (PLRX) Change in Cash (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Change in Cash for 8 consecutive years, with -$23.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 212.08% year-over-year to -$23.3 million; the TTM figure through Mar 2026 stood at -$69.7 million (down 211.91% YoY), while the FY2025 annual figure was -$25.7 million, down 423.65% from the prior year.
- Change in Cash climbed to -$23.3 million in Q1 2026 per PLRX's latest filing, from -$48.3 million in the prior quarter.
- Across five years, Change in Cash topped out at $68.8 million in Q1 2023 and bottomed at -$48.3 million in Q4 2025.
- Historically, Change in Cash has averaged -$1.6 million across 5 years, with a median of -$5.1 million in 2025.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 30249.21% — and 2025, when it jumped 997.66%.
- Pliant Therapeutics' Change in Cash stood at -$10.9 million in 2022, then surged by 164.37% to $7.0 million in 2023, then plunged by 219.75% to -$8.4 million in 2024, then slumped by 472.94% to -$48.3 million in 2025, then jumped by 51.84% to -$23.3 million in 2026.
- Business Quant data shows PLRX's Change in Cash at -$23.3 million in Q1 2026, -$48.3 million in Q4 2025, and $6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - | 2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.69 Mn |
| Mar 31, 2026 | -23.26 Mn |
| Dec 31, 2025 | -48.29 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | -5.12 Mn |
| Mar 31, 2025 | 20.75 Mn |
| Dec 31, 2024 | -8.43 Mn |
| Sep 30, 2024 | -770,000.00 |
| Jun 30, 2024 | -33.91 Mn |
| Mar 31, 2024 | 51.06 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | -47.58 Mn |
| Mar 31, 2023 | 68.84 Mn |
| Dec 31, 2022 | -10.93 Mn |
| Sep 30, 2022 | 19.55 Mn |
| Jun 30, 2022 | -7.48 Mn |
| Mar 31, 2022 | -19.12 Mn |
| Dec 31, 2021 | 6.43 Mn |
| Sep 30, 2021 | 10.04 Mn |